Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
Status:
Terminated
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess efficacy and tolerability of changing to DuoTrav®
(Travoprost 0.004%/Timolol 0.5% BAK-free) from prior Xalacom® or Ganfort® fixed combination
pharmacotherapy in patients with open-angle glaucoma or ocular hypertension with uncontrolled
intraocular pressure (IOP).